Immunomic Therapeutics, Inc.
www.immunomix.comImmunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.
Read more
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.
Read more
Country
State
Maryland
City (Headquarters)
Rockville
Industry
Employees
11-50
Founded
2005
Estimated Revenue
$5,000,000 to $10,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Advisory Board Member
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****Board of Directors
Email ****** @****.comPhone (***) ****-****Senior Quality Assurance Manager
Email ****** @****.comPhone (***) ****-****
Technologies
(24)
